Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2009 15:47 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Transfer to Nasdaq Capital Market

TEMPE, Ariz., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (the "Company") (Nasdaq:CAPS) today announced that its application to transfer the listing of its common stock from The Nasdaq...
November 09, 2009 08:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Third Quarter 2009 Financial Results

TEMPE, Ariz., Nov. 9, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the third quarter 2009. The...
November 04, 2009 08:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics to Host Conference Call Discussing Third Quarter 2009 Operating Results

TEMPE, Az., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), will host a conference call and webcast presenting third quarter 2009...
October 22, 2009 16:51 ET | Source: Capstone Therapeutics

Capstone Therapeutics to Present at 4th Annual BIOCOM Investor Conference

TEMPE, Ariz., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) is scheduled to make a presentation at the BIOCOM Investor Conference, Hyatt Regency La Jolla (CA) on October 26,...
October 13, 2009 15:35 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Presentation of Chrysalin(R) (TP508) Pre-Clinical Data At the American College of Surgeons 95th Annual Clinical Conference Demonstrating Significant Benefit in a Model of Acute Heart Disease and Elevated Cholesterol

TEMPE, Ariz., Oct. 13, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) today announced the presentation of pre-clinical data at the American College of Surgeons 95th Annual Clinical...
September 30, 2009 08:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Completion of Enrollment for Second of Two AZX100 Phase 2 Studies in Keloid Scarring; Phase 2 Study in Shoulder Surgery Scarring Reaches Enrollment Milestone

TEMPE, Ariz., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the completion of enrollment for the second of its two ongoing AZX100 Phase 2 clinical trials in...
August 12, 2009 06:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Second Quarter 2009 Financial Results

TEMPE, Ariz., Aug. 12, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the second quarter...
August 04, 2009 14:30 ET | Source: Capstone Therapeutics

Capstone Therapeutics to Host Conference Call Discussing Second Quarter 2009 Operating Results

TEMPE, Ariz., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company") will host a conference call and webcast presenting second quarter...
July 14, 2009 08:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Completion of Enrollment for First of Two AZX100 Phase 2 Pilot Studies in Keloid Scarring

TEMPE, Ariz., July 14, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the completion of enrollment for the first of its two ongoing AZX100 Phase 2 pilot clinical trials...
May 11, 2009 06:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces First Quarter 2009 Financial Results

TEMPE, Ariz., May 11, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the first quarter 2009. The...